InvestorsHub Logo
Followers 139
Posts 8138
Boards Moderated 0
Alias Born 05/06/2009

Re: None

Thursday, 11/10/2016 8:25:05 AM

Thursday, November 10, 2016 8:25:05 AM

Post# of 402378
Is everyone forgetting that this is a pharmaceutical company with drugs in development? Share price is based off balance sheet and potential balance sheet upon pipeline drug approvals. We're not in various 1,2 or 3 phases, we're at the approval part. Most small cap drug companies operate above These price levels with no income or deals in the working at all. We're talking about a patented technology for opioid abuse that can be used with other drugs. I'm not saying they'll get approval, or this company is a $3 company, what I'm saying is we all shouldn't jump off the deep end because revenue is down for the quarter 7%..... it's still better all in all than last year by 18% with enough cash to get them through forecasted sequestox approval. Share price is going to take a hit, I'm sure of that, and if you feel like you need to sell then do so, I probably might sell some too, but BUY BACK IN, when you think it's gone as low as it can because there is a lot of upside here. A CRL is not a rejection, it's the FDA saying "you can get approved if you do A, B or C"...this is a stock for trading, not investing, take profits along the way and when it peaks get out. Play the game everyone and good luck to all, both pumpers and dumpers alike..lol we're all trying to make a buck

idleness is the only refugee of weak minds

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News